Seminars in Neuroscience

Strategies for Treatment of Opiate Abuse
pp. 69-69(1)
Authors: Herman B.; Iversen L.

Molecular and Neuroanatomical Properties of the Endogenous Opioid System: Implications for Treatment of Opiate Addiction
pp. 70-83(14)
Authors: Akil H.; Meng F.; Devine D.P.; Watson S.J.

Molecular Mechanisms Underlying Opiate Addiction: Implications for Medications Development
pp. 84-93(10)
Author: Nestler E.J.

Preclinical Behavioral Models for Addressing Unmet Needs in Opiate Addiction
pp. 94-109(16)
Authors: Schulteis G.; Gold L.H.; Koob G.F.

Preclinical Evidence for a Role of Glutamatergic Systems in Opioid Tolerance and Dependence
pp. 110-119(10)
Author: Inturrisi C.E.

Brain Imaging Studies of Drug Abuse: Therapeutic Implications
pp. 120-130(11)
Authors: Ernst M.; London E.D.

Organization of Opioid Receptors in Human Brain and Drug Interactions Studied by PET and SPECT Imaging: Implications for Treatment Strategies for Opiate Addiction
pp. 131-139(9)
Authors: Melichar J.K.; Malizia A.L.; Nutt D.J.

Clinical Update of Opioid Agonist and Partial Agonist Medications for the Maintenance Treatment of Opioid Addiction
pp. 140-157(18)
Author: Kreek M.J.

Clinical Medications Development for Opiate Addiction: Focus on Nonopioids and Opioid Antagonists for the Amelioration of Opiate Withdrawal Symptoms and Relapse Prevention
pp. 158-172(15)
Authors: Herman B.H.; O'Brien C.P.